Urinary Tract Cancers
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers (NCT02675829) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
Track Urinary Tract Cancers automatically
Every clearance here is in the API, with alerts when new ones post.